Most Likely Diagnosis for a Patient with CBC Findings

What is the most likely diagnosis for a patient with the following CBC findings? WBC: 8.8 × 103/µl; RBC: 3.01 × 103/µl; Hgb: 10.3 g/dL; Hct: 32.2%; MCV: 74 fL; MCHC: 28.3 g/dL; Plt: 400 × 103/µl; RDW: 18.4%; Reticulocytes: 2.1%.

Identify which anemia is the patient experiencing, which tests should be ordered and what type of treatment should be followed.

The CBC findings provided for the patient indicate the following abnormalities:

1. RBC: Decreased at 3.01 × 10³/µl (normal range: 4.7–6.1 × 10³/µl for men; 4.2–5.4 × 10³/µl for women).
2. Hgb (Hemoglobin): Decreased at 10.3 g/dL (normal range: 13.5–17.5 g/dL for men; 12.0–15.5 g/dL for women).
3. Hct (Hematocrit): Decreased at 32.2% (normal range: 41%–50% for men; 36%–44% for women).
4. MCV (Mean Corpuscular Volume): Decreased at 74 fL, indicating microcytic anemia (normal range: 80–100 fL).
5. MCHC (Mean Corpuscular Hemoglobin Concentration): Decreased at 28.3 g/dL, suggesting hypochromic red blood cells (normal range: 32–36 g/dL).
6. RDW (Red Cell Distribution Width): Elevated at 18.4% (normal range: 11.5%–14.5%), indicating variability in red blood cell size.
7. Reticulocyte Count: Slightly elevated at 2.1% (normal range: 0.5%–2.0%), indicating some bone marrow response to anemia.
8. Platelets: Normal at 400 × 10³/µl.

Most Likely Diagnosis

The most likely diagnosis is iron deficiency anemia. The combination of microcytosis (low MCV), hypochromia (low MCHC), and elevated RDW is highly suggestive of iron deficiency anemia. The slightly elevated reticulocyte count may indicate the body is attempting to compensate by producing more red blood cells, albeit insufficiently.

Additional Tests

To confirm the diagnosis and identify the underlying cause, the following tests should be ordered:

1. Serum Ferritin: Decreased ferritin levels confirm iron deficiency.
2. Serum Iron: Typically low in iron deficiency anemia.
3. Total Iron-Binding Capacity (TIBC): Usually elevated in iron deficiency.
4. Transferrin Saturation: Decreased in iron deficiency.
5. Peripheral Blood Smear: To assess the morphology of red blood cells.
6. Occult Blood Test (Stool Test): To rule out gastrointestinal bleeding as a cause of chronic iron loss.
7. Endoscopy/Colonoscopy: If GI bleeding is suspected.

Treatment

Treatment should focus on correcting the iron deficiency and addressing the underlying cause:

1. Iron Supplementation:
   • Oral iron supplements such as ferrous sulfate (325 mg once daily or three times daily) are the first-line treatment. They should be taken with vitamin C to enhance absorption.
   • Side effects may include gastrointestinal discomfort and constipation, which can be mitigated by adjusting the dose or using a liquid formulation.
2. Dietary Modifications:
   • Encourage consumption of iron-rich foods, such as red meat, poultry, fish, leafy green vegetables, legumes, and iron-fortified cereals.
   • Avoid calcium and caffeine around mealtime, as they can inhibit iron absorption.
3. IV Iron Therapy:
   • For patients who cannot tolerate oral iron or have severe anemia requiring rapid correction, intravenous iron (e.g., iron sucrose or ferric carboxymaltose) may be administered.
4. Treat the Underlying Cause:
   • If chronic blood loss (e.g., from heavy menstrual bleeding or gastrointestinal conditions) is identified, it should be treated to prevent recurrence.

Follow-up monitoring of hemoglobin and ferritin levels should be conducted in 4–6 weeks to assess the response to therapy and ensure effective management.

The post Most Likely Diagnosis for a Patient with CBC Findings appeared first on Nursing Depo.